AbbVie Inc. Total Liabilities & Equity 2012-2026 | ABBV
Beta
What is total liabilities & equity?
Total liabilities and stockholders' equity equals total assets, reflecting the fundamental accounting equation.
What is AbbVie Inc.'s current total liabilities & equity?
AbbVie Inc. (ABBV) annual total liabilities & equity for 2025 was $133.96B, a 0.89% decline from 2024. AbbVie Inc. total liabilities & equity for the quarter ending March 31, 2026 was $136.46B.
What was AbbVie Inc.'s total liabilities & equity in 2024?
AbbVie Inc. annual total liabilities & equity for 2024 was $135.16B, a 0.33% increase from 2023.
What was AbbVie Inc.'s total liabilities & equity in 2023?
AbbVie Inc. annual total liabilities & equity for 2023 was $134.71B, a 2.95% decline from 2022.
What is AbbVie Inc.'s 5-year total liabilities & equity CAGR?
AbbVie Inc. total liabilities & equity grew at a compound annual growth rate (CAGR) of 2.31% from FY2020 to FY2025, going from $150.56B to $133.96B over 5 years.
Total Liabilities & Equity History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-2.3%
FY2020
$150.56B
→
FY2025
$133.96B
1213141516171819202122232425
5 years selected
Total Liabilities & Equity History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $133.96B | -0.9% | 10-K |
| FY2024 | $135.16B | +0.3% | 10-K |
| FY2023 | $134.71B | -2.9% | 10-K |
| FY2022 | $138.81B | -5.3% | 10-K |
| FY2021 | $146.53B | -2.7% | 10-K |
| FY2020 | $150.56B | +69.0% | 10-K |
| FY2019 | $89.11B | +50.1% | 10-K |
| FY2018 | $59.35B | -16.2% | 10-K |
| FY2017 | $70.79B | +7.1% | 10-K |
| FY2016 | $66.10B | +24.6% | 10-K |
| FY2015 | $53.05B | +92.8% | 10-K |
| FY2014 | $27.51B | -5.8% | 10-K |
| FY2013 | $29.20B | +8.1% | 10-K |
| FY2012 | $27.01B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →